Prosecution Insights
Last updated: April 19, 2026
Application No. 18/039,731

METHODS AND SYSTEMS FOR MEDICATION MANAGEMENT AND EFFECTIVENESS QUANTIFICATION

Final Rejection §101
Filed
Jun 01, 2023
Examiner
COLEMAN, CHARLES P.
Art Unit
3683
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
Koninklijke Philips N V
OA Round
2 (Final)
16%
Grant Probability
At Risk
3-4
OA Rounds
4y 7m
To Grant
35%
With Interview

Examiner Intelligence

Grants only 16% of cases
16%
Career Allow Rate
83 granted / 519 resolved
-36.0% vs TC avg
Strong +19% interview lift
Without
With
+19.2%
Interview Lift
resolved cases with interview
Typical timeline
4y 7m
Avg Prosecution
41 currently pending
Career history
560
Total Applications
across all art units

Statute-Specific Performance

§101
50.2%
+10.2% vs TC avg
§103
39.4%
-0.6% vs TC avg
§102
4.5%
-35.5% vs TC avg
§112
3.2%
-36.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 519 resolved cases

Office Action

§101
DETAILED ACTION Notice to Applicant This action is in reply to the filed on 7/10/2025. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 1 and 10 have been amended. Claims 2 and 11 have been cancelled. Claim 1, 3-10 and 12-15 currently pending and have been examined. Response to Amendments The Applicant’s amendments, and cancellation, of the claims as currently submitted have been noted by the Examiner. Said amendments, and cancellation(s), are not sufficient to overcome the rejection previously set forth under 35 U.S.C. §101. As such, said rejection is herein maintained for reasons set forth below. With the amendment of claims 1 and 10, and the cancellation of claims 2 and 11, applicant has successfully overcome the Examiner’s 35 USC 103 rejection and Examiner withdraws his 35 USC 103 rejection. Narasimhan et al. and Kheir et al. do not teach “generating a medication status score," "identifying one or more events in the received signal based on selection criteria,” etc. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Human Interactions Organized Applicant discloses (Applicant’s Specification, [0002]) that many chronic conditions require pharmacological management. So a need exists to organize these human interactions by/through analyzing medication dosage for patients using the steps of “receiving signals, receiving information, analyzing signals, generating medication status scores, identifying events, extracting quality metrics, aggregating quality metrics,” etc. Applicant’s method is therefore a certain method of organizing the human activities as described and disclosed by Applicant. Rejection Claim(s) 1, 3-10 and 12-15 is/are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. Claim(s) 1 and 10 is/are directed to the abstract idea of “analyzing medication dosage for patients,” etc. (Applicant’s Specification, Abstract, paragraph(s) [0001]), etc., as explained in detail below, and thus grouped as a certain method of organizing human interactions. The claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception because the additional computer elements, which are recited at a high level of generality, provide conventional computer functions that do not add meaningful limits to practicing the abstract idea. Accordingly, claims 1, 3-10 and 12-15 recite an abstract idea. Step 2A Prong 1 – The Judicial Exception The claim(s) recite(s) in part, method for performing the steps of “receiving signals, receiving information, analyzing signals, generating medication status scores, identifying events, extracting quality metrics, aggregating quality metrics,” etc., that is “analyzing medication dosage for patients,” etc. which is a method of managing personal behavior or relationships or interactions between people (social activities, teaching, following rules, instructions) and thus grouped as a certain method of organizing human interactions. Accordingly, claims 1, 3-10 and 12-15 recite an abstract idea. Step 2A Prong 2 – Integration of the Judicial Exception into a Practical Application This judicial exception is not integrated into a practical application because the generically recited additional computer elements (i.e. memories, user interfaces, sensors, controllers, communication modules, batteries, processors, displays (Applicant’s Specification [0044]-[0053]), etc.) to perform steps of “receiving signals, receiving information, analyzing signals, generating medication status scores, identifying events, extracting quality metrics, aggregating quality metrics,” etc. do not add a meaningful limitation to the abstract idea because they amount to simply implementing the abstract idea on a computer and this is nothing more than an attempt to generally link the product of nature to a particular technological environment. Accordingly, this additional element does not integrate the abstract idea into a practical application because it does not impose any meaningful limit on practicing the abstract idea. Accordingly, the claims are directed to an abstract idea. Insignificant extra-solution activity Claim(s) 1, 3-10 and 12-15 recites storing data steps, retrieving data steps, providing data steps, output steps (Bilski v. Kappos, 561 U.S. 593, 610-12 (2010), Bancorp Servs., L.L.C. v. Sun Life Assur. Co. of Can., 771 F.Supp.2d 1054, 1066 (E.D. Mo. 2011), aff’d, 687 F.3d at 1266), and/or transmitting data step (buySAFE, Inc. v. Google, Inc., 765 F.3d 1350, 1355 (Fed. Cir. 2014), Apple, Inc. v. Ameranth, Inc., 842 F.3d 1299, 1241-42 (Fed. Cir. 2016)) that is/are insignificant extra-solution activity. Extra-solution activity limitations are insufficient to transform judicially excepted subject matter into a patent-eligible application (MPEP §2106.05(g)). Step 2B – Search for an Inventive Concept/Significantly More The claim(s) does/do not include additional elements that are sufficient to amount to significantly more than the judicial exception because as discussed above with respect to integration into a practical application, the additional elements (i.e. memories, user interfaces, sensors, controllers, communication modules, batteries, processors, displays, etc.) are recited at a high level of generality, and the written description indicates that these elements are generic computer components. Using generic computer components to perform abstract ideas does not provide a necessary inventive concept (Alice, 573 U.S. at 223 (“mere recitation of a generic computer cannot transform a patent-ineligible abstract idea into a patent-eligible invention.”)). Accordingly, the claims are not patent eligible. Individually and in Combination The additional elements when considered both individually and as an ordered combination do not amount to significantly more than the abstract idea. The additional elements amount to no more than generic computer components that serve to merely link the abstract idea to a particular technological environment (i.e. memories, user interfaces, sensors, controllers, communication modules, batteries, processors, displays, etc.). At paragraph(s) [0044]-[0053], Applicant’s specification describes generic computer hardware for implementing the above described functions including “memories, user interfaces, sensors, controllers, communication modules, batteries, processors, displays,” etc. to perform the functions of “receiving signals, receiving information, analyzing signals, generating medication status scores, identifying events, extracting quality metrics, aggregating quality metrics,” etc. The recited “memories, user interfaces, sensors, controllers, communication modules, batteries, processors, displays,” etc. does/do not add meaningful limitations to the idea of beyond generally linking the system to a particular technological environment, that is, implementation via computers. Thus, taken alone, the additional elements do not amount to significantly more than the above-identified judicial exception (the abstract idea). Looking at the limitations as an ordered combination adds nothing that is not already present when looking at the elements taken individually. There is no indication that the combination of elements improves the functioning of a computer, or improves any other technology, or improves a technical field, or provides a technical improvement to a technical problem. Their collective functions merely provide generic computer implementation. Therefore, claims 1, 3-10 and 12-15 do not amount to significantly more than the underlying abstract idea of “an idea of itself” (Alice). Dependent Claims Dependent claim(s) 3-9 and 12-15 include(s) all the limitations of the parent claims and are directed to the same abstract idea as discussed above and incorporated herein. Although dependent claims 3-9 and 12-15 add additional limitations, they only serve to further limit the abstract idea by reciting limitations on what the information is and how it is received and used. Dependent claims 3-9 and 12-15 merely describe physical structures to implement the abstract idea. These information and physical characteristics do not change the fundamental analogy to the abstract idea grouping of certain method of organizing human interactions, and when viewed individually or as a whole, they do not add anything substantial beyond the abstract idea. Furthermore, the combination of elements does not indicate a significant improvement to the functioning of a computer or any other technology. Therefore, the claims when taken as a whole are ineligible for the same reasons as independent claim(s) 1 and 10. Response to Arguments Applicant’s arguments filed 7/10/2025 with respect to claims 1, 3-10 and 12-15 have been fully considered and they are partially persuasive. Applicant’s arguments will be addressed herein below in the order in which they appear in the response filed 7/10/2025. Applicant’s arguments filed on 7/10/2025 with respect to claims 1, 3-10 and 12-15 have been fully considered but are moot in view of the new ground(s) of rejection. Applicant argues that (A) Narasimhan et al. and Kheir et al. do not render obvious the present invention because Narasimhan et al. and Kheir et al. do not disclose “generating a medication status score," "identifying one or more events in the received signal based on selection criteria,” etc. in the previously presented and/or presently amended claims, (B) the Applicant’s claimed invention is directed to statutory matter. 103 Responses In response to Applicant’s argument (A), Applicant’s arguments with regard to the application of Narasimhan et al. and Kheir et al. to the amended limitations have been found persuasive. Narasimhan et al. and Kheir et al. do not teach “generating a medication status score," "identifying one or more events in the received signal based on selection criteria.” Applicant has successfully overcome the Examiner’s 35 USC 103 rejection and Examiner withdraws his 35 USC 103 rejection. 101 Responses As per Applicant’s argument (B), Applicant’s remarks with regard to the statutory nature of Applicant’s claimed invention are addressed above in the Office Action. Applicant’s Amendments Applicant amended claims recite “generating a medication status,” “identifying one or more events in the received signal based on selection criteria,” “extracting a quality metric from each of the identified one or more events,” “aggregating the extracted quality metrics from the one or more events for the first time period.” These are information processing steps that is part of Applicant’s abstract idea and does not move Applicant’s invention into eligible subject matter. Applicant’s argument is not persuasive. Enfish Further, the claims in Enfish, LLC v. Microsoft Corp. provide a technical solution to a problem rooted in computer technology (i.e. database software designed as a “self-referential” database). Simply adding a generic computing device that performs routine and conventional functions or presenting abstract claims that are directed to generalized steps to be performed on a computer using conventional computer activity (i.e. receiving signals, receiving information, analyzing signals, generating medication status scores, identifying events, extracting quality metrics, aggregating quality metrics, etc.) is not equivalent or similar to addressing a database challenge as is the case in Enfish, LLC v. Microsoft Corp. While the claims are directed to a process that is performed on a computer, they are not directed to a business challenge that is particular to databases. In fact, the claims are not directed to the use “self-referential” databases at all or functions that are particular to “self-referential” databases as is the case in the claims of Enfish, LLC v. Microsoft Corp. Therefore, because the claims fail to provide a technical solution to any database challenges, the ordered combination of limitations do not amount to significantly more than a method of managing interactions between people and thus grouped as a certain method of organizing human interactions. Accordingly, the claims recite an abstract idea. As explained above, this judicial exception is not integrated into a practical application. Further, as explained above, the claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception. Accordingly, the claims are not patent eligible. Applicant’s argument is not persuasive. Conclusion Applicant’s amendment necessitated the new ground(s) for rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set for in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension free pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHARLES P. COLEMAN whose telephone number is (571) 270-7788. The examiner can normally be reached on Monday through Thursday 7:30a - 5:00p. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, ROBERT W. MORGAN can be reached on (571) 272-6773. The fax phone number for the organization where this application or proceeding is assigned is (571) 273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /C. P. C./ Examiner, Art Unit 3683 /ROBERT W MORGAN/Supervisory Patent Examiner, Art Unit 3683
Read full office action

Prosecution Timeline

Jun 01, 2023
Application Filed
Mar 08, 2025
Non-Final Rejection — §101
Jul 10, 2025
Response Filed
Nov 30, 2025
Final Rejection — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12591781
METHODS AND SYSTEMS FOR DETERMINING OPTIMAL DECISION TIME RELATED TO EMBRYONIC IMPLANTATION
2y 5m to grant Granted Mar 31, 2026
Patent 12482545
Portable Medical Memory
2y 5m to grant Granted Nov 25, 2025
Patent 12376778
ECG FEATURES FOR TYPE AHEAD EDITING AND AUTOMATIC UPDATE FOR REPORT INTERPRETATION
2y 5m to grant Granted Aug 05, 2025
Patent 12347336
CARE PLAN ADMINISTRATION: PATIENT FEEDBACK
2y 5m to grant Granted Jul 01, 2025
Patent 12300368
ANALYSIS AND PRESENTATION OF AGGREGATED PATIENT AND DEVICE DATA WITHIN A SYSTEM THAT INCLUDES A MEDICAL DEVICE
2y 5m to grant Granted May 13, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
16%
Grant Probability
35%
With Interview (+19.2%)
4y 7m
Median Time to Grant
Moderate
PTA Risk
Based on 519 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month